Results for “”

Entry Author Date Location
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink 12/11/19 National
Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics 12/11/19 Boston
Flexion Co-Founder, Chief Scientific Officer Neil Bodick to Retire 12/10/19 Boston
Replimune Taps Ex-Merrimack Exec for Chief Financial Officer Post 12/10/19 Boston
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test 12/10/19 Boston
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule 12/09/19 New York
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets 12/09/19 Boston
3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug 12/06/19 San Diego
Akcea Therapeutics Appoints Alex Howarth Chief Operating Officer 12/06/19 Boston
FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal 12/06/19 National
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results 12/05/19 National
FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder 12/05/19 Boston
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60% 12/05/19 Boston
As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug 12/05/19 San Diego
Avrobio’s Gabriel Cohn Joins Homology as Chief Medical Officer 12/04/19 Boston
Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding 12/04/19 Boston
Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption 12/04/19 Raleigh Durham
Repare Therapeutics Taps Clementia Pharma’s Steve Forte As Its New CFO 12/03/19 Boston
Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down 12/03/19 Seattle
Caraway Therapeutics Names Martin Williams as CEO 12/03/19 Boston
IFM’s Glick Becomes Executive Chairman, Seidel Promoted to CEO 12/02/19 Boston
Agenus Chief Technology Officer Alex Duncan to Depart in January 12/02/19 Boston
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator 12/02/19 Boston
La Jolla Pharma’s Share Price Halves On Trial End, CEO Departure 11/26/19 San Diego
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule 11/25/19 San Francisco
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M 11/25/19 Boston
Axcella Taps Incyte’s Laurent Chardonnet as Chief Financial Officer 11/25/19 Boston
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
Page 1 of 661 next page »